ESR2 and neoplasm: Because of genistein's preferential binding to ERβ [57], [58] and the high and exclusive expression of ERβ in our tumor line (no ERα expression; Figure S2), it can be hypothesized that genistein's tumor stimulatory effects observed in this study may be mediated via ERβ activation.